These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31987674)

  • 1. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
    Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst.
    Cha YH; Cho ES; Kang HE; Ko J; Nam W; Kim HJ; Kim NH; Kim HS; Cha IH; Yook JI
    Oral Oncol; 2017 Nov; 74():62-67. PubMed ID: 29103753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of odontogenic cysts and tumours.
    Gomes IP; Bastos VC; Guimarães LM; Gomes CC
    J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
    Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
    Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas.
    Ji YD; Johnson DN; Faquin WC; Peacock ZS
    Int J Oral Maxillofac Surg; 2024 Feb; 53(2):122-126. PubMed ID: 37344275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of BRAF V600E mutation in Iranian population ameloblastomas.
    Derakhshan S; Aminishakib P; Karimi A; Saffar H; Abdollahi A; Mohammadpour H; Kharazi Fard MJ; Memarha A
    Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e502-e507. PubMed ID: 32388526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
    Pei J; Zhang L; Jia YX; Chen WH
    Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Study of
    Kokubun K; Yamamoto K; Akashi Y; Chujo T; Nakajima K; Matsuzaka K
    Int J Surg Pathol; 2022 Jun; 30(4):378-384. PubMed ID: 34994576
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population.
    Goes CF; Spadigam A; Dhupar A; Carvalho KM; Cota J; Syed S
    Indian J Pathol Microbiol; 2023; 66(2):246-251. PubMed ID: 37077063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Odontogenic keratocyst and ameloblastoma: radiographic evaluation.
    Kitisubkanchana J; Reduwan NH; Poomsawat S; Pornprasertsuk-Damrongsri S; Wongchuensoontorn C
    Oral Radiol; 2021 Jan; 37(1):55-65. PubMed ID: 32030659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
    Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
    Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
    Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of BRAF-V600E mutation to ameloblastoma metabolism.
    Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
    Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
    Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MDM2 Overexpression in Ameloblastomas with
    Tosios KI; Kalogirou EM; Koutlas IG
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: Comparative analysis of two VE1 antibodies.
    Oh KY; Cho SD; Yoon HJ; Lee JI; Hong SD
    J Oral Pathol Med; 2021 Jan; 50(1):85-91. PubMed ID: 32939809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review.
    González-González R; López-Verdín S; Lavalle-Carrasco J; Molina-Frechero N; Isiordia-Espinoza M; Carreón-Burciaga RG; Bologna-Molina R
    World J Clin Oncol; 2020 Jan; 11(1):31-42. PubMed ID: 31976308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mutational Profile of Unicystic Ameloblastoma.
    Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
    J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
    Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
    J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma.
    Mendez LD; Wolsefer NS; Asa SL; Wasman J; Yoest JM; Stojanov IJ
    Mod Pathol; 2022 Nov; 35(11):1570-1577. PubMed ID: 35676332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.